OBJECTIVE: To examine predictors of depression persistence after a positive screening test to inform management protocols for screened youth. METHODS: We conducted a cohort study of 444 youth (aged 13-17 years) from a large health care delivery system. Youth with depressive symptoms, based on a 2-item depression screen, were oversampled for the baseline interview. Baseline assessments included the Patient Health Questionnaire 9-item (PHQ-9) depression screen as well as clinical factors that were hypothesized to influence depression persistence (family history of depression, functional impairment, perceived social support, anxiety symptoms, externalizing symptoms, and medical comorbidity). Logistic regression analysis was used to examine factors associated with the persistence of depression at 6 months postbaseline. RESULTS: Of 113 youth with a positive baseline screen (PHQ-9 ≥11), 47% and 35% continued to be positive at 6-week and 6-month follow-up, respectively. After controlling for treatment status, only 2 factors were significantly associated with depression persistence at 6 months: baseline depressive symptom score and continuing to have a positive screen at 6 weeks. For each 1-point increase on the PHQ-9 score at baseline, youth had a 16% increased odds of continuing to be depressed at 6 months (odds ratio: 1.16, 95% confidence interval: 1.01-1.34). Youth who continued to screen positive 6 weeks later had almost 3 times the odds of being depressed at 6 months (odds ratio: 2.89, 95% confidence interval: 1.09-7.61). CONCLUSIONS: Depressive symptom severity at presentation and continued symptoms at 6 weeks postscreening are the strongest predictors of depression persistence. Patients with high depressive symptom scores and continued symptoms at 6 weeks should receive active treatment.
OBJECTIVE: To examine predictors of depression persistence after a positive screening test to inform management protocols for screened youth. METHODS: We conducted a cohort study of 444 youth (aged 13-17 years) from a large health care delivery system. Youth with depressive symptoms, based on a 2-item depression screen, were oversampled for the baseline interview. Baseline assessments included the Patient Health Questionnaire 9-item (PHQ-9) depression screen as well as clinical factors that were hypothesized to influence depression persistence (family history of depression, functional impairment, perceived social support, anxiety symptoms, externalizing symptoms, and medical comorbidity). Logistic regression analysis was used to examine factors associated with the persistence of depression at 6 months postbaseline. RESULTS: Of 113 youth with a positive baseline screen (PHQ-9 ≥11), 47% and 35% continued to be positive at 6-week and 6-month follow-up, respectively. After controlling for treatment status, only 2 factors were significantly associated with depression persistence at 6 months: baseline depressive symptom score and continuing to have a positive screen at 6 weeks. For each 1-point increase on the PHQ-9 score at baseline, youth had a 16% increased odds of continuing to be depressed at 6 months (odds ratio: 1.16, 95% confidence interval: 1.01-1.34). Youth who continued to screen positive 6 weeks later had almost 3 times the odds of being depressed at 6 months (odds ratio: 2.89, 95% confidence interval: 1.09-7.61). CONCLUSIONS:Depressive symptom severity at presentation and continued symptoms at 6 weeks postscreening are the strongest predictors of depression persistence. Patients with high depressive symptom scores and continued symptoms at 6 weeks should receive active treatment.
Authors: M B Keller; N D Ryan; M Strober; R G Klein; S P Kutcher; B Birmaher; O R Hagino; H Koplewicz; G A Carlson; G N Clarke; G J Emslie; D Feinberg; B Geller; V Kusumakar; G Papatheodorou; W H Sack; M Sweeney; K D Wagner; E B Weller; N C Winters; R Oakes; J P McCafferty Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-07 Impact factor: 8.829
Authors: Laura P Richardson; Elizabeth McCauley; David C Grossman; Carolyn A McCarty; Julie Richards; Joan E Russo; Carol Rockhill; Wayne Katon Journal: Pediatrics Date: 2010-11-01 Impact factor: 7.124
Authors: Graham J Emslie; John H Heiligenstein; Karen Dineen Wagner; Sharon L Hoog; Daniel E Ernest; Eileen Brown; Mary Nilsson; Jennie G Jacobson Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-10 Impact factor: 8.829
Authors: David J Breland; Carolyn A McCarty; Chuan Zhou; Elizabeth McCauley; Carol Rockhill; Wayne Katon; Laura P Richardson Journal: Gen Hosp Psychiatry Date: 2013-12-10 Impact factor: 3.238
Authors: Carolyn A McCarty; Douglas Zatzick; Elizabeth Stein; Jin Wang; Robert Hilt; Frederick P Rivara Journal: Pediatrics Date: 2016-09-13 Impact factor: 7.124
Authors: Peter H Silverstone; Marni Bercov; Victoria Y M Suen; Andrea Allen; Ivor Cribben; Jodi Goodrick; Stu Henry; Catherine Pryce; Pieter Langstraat; Katherine Rittenbach; Samprita Chakraborty; Rutger C Engels; Christopher McCabe Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240
Authors: Willem Kuyken; Elizabeth Nuthall; Sarah Byford; Catherine Crane; Tim Dalgleish; Tamsin Ford; Mark T Greenberg; Obioha C Ukoumunne; Russell M Viner; J Mark G Williams Journal: Trials Date: 2017-04-26 Impact factor: 2.279
Authors: Andrea M Knight; Michelle E Vickery; Alexander G Fiks; Frances K Barg Journal: Pediatr Rheumatol Online J Date: 2015-11-24 Impact factor: 3.054
Authors: Derrick Ssewanyana; Moses Kachama Nyongesa; Anneloes van Baar; Charles R Newton; Amina Abubakar Journal: Child Adolesc Psychiatry Ment Health Date: 2017-07-17 Impact factor: 3.033